Identification and Functional Characterization of Long Non-coding RNA<i> MIR22HG</i> as a Tumor Suppressor for Hepatocellular Carcinoma

Dongyan Zhang(Shandong University), Dehua Wu(Nanfang Hospital), Xuejing Zou(Nanfang Hospital), Li Liu(National Clinical Research Center for Digestive Diseases), Ting Zhang(Second Hospital of Tianjin Medical University), Xiaolong Qi(First Hospital of Lanzhou University), Chuanhui Cao(Ganzhou People's Hospital), Ling Lei(Nanfang Hospital)
Theranostics
January 1, 2018
10.7150/thno.22493
Cited by 90

Related Papers

Pre-existing liver disease is associated with poor outcome in patients with SARS CoV2 infection; The APCOLIS Study (APASL COVID-19 Liver Injury Spectrum Study)
|Hepatology International|2020|295
The Long Intergenic Noncoding RNA UFC1, a Target of MicroRNA 34a, Interacts With the mRNA Stabilizing Protein HuR to Increase Levels of β-Catenin in HCC Cells
|Gastroenterology|2014|231
ATR inhibitor AZD6738 enhances the antitumor activity of radiotherapy and immune checkpoint inhibitors by potentiating the tumor immune microenvironment in hepatocellular carcinoma
|Journal for ImmunoTherapy of Cancer|2020|225
Residual convolutional neural network for predicting response of transarterial chemoembolization in hepatocellular carcinoma from CT imaging
|European Radiology|2019|219
miR-139-5p inhibits aerobic glycolysis, cell proliferation, migration, and invasion in hepatocellular carcinoma via a reciprocal regulatory interaction with ETS1
|Oncogene|2018|142